Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 147 contracts
Samples: Underwriting Agreement (Nuvve Holding Corp.), Securities Purchase Agreement (Aptevo Therapeutics Inc.), Securities Purchase Agreement (Cineverse Corp.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 68 contracts
Samples: Underwriting Agreement (Coeptis Therapeutics Holdings, Inc.), Underwriting Agreement (Kiora Pharmaceuticals Inc), Underwriting Agreement (Auddia Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 30 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 65 contracts
Samples: Securities Purchase Agreement (Recruiter.com Group, Inc.), Securities Purchase Agreement (Ensysce Biosciences, Inc.), Securities Purchase Agreement (Eyegate Pharmaceuticals Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 62 contracts
Samples: Underwriting Agreement (Intelligent Bio Solutions Inc.), Underwriting Agreement (Can B Corp), Securities Purchase Agreement (NextPlay Technologies Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 32 contracts
Samples: Form of Securities Purchase Agreement (Golden Matrix Group, Inc.), Form of Securities Purchase Agreement (Sigma Labs, Inc.), Securities Purchase Agreement (Cleveland Biolabs Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 29 contracts
Samples: Securities Purchase Agreement (Statera Biopharma, Inc.), Securities Purchase Agreement (Creek Road Miners, Inc.), Securities Purchase Agreement (Creatd, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 28 contracts
Samples: Securities Purchase Agreement (Hoth Therapeutics, Inc.), Securities Purchase Agreement (Apollo Endosurgery, Inc.), Securities Purchase Agreement (Apollo Endosurgery, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 24 contracts
Samples: Securities Purchase Agreement (Ideal Power Inc.), Securities Purchase Agreement (Aytu Bioscience, Inc), Securities Purchase Agreement (Streamline Health Solutions Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 22 contracts
Samples: Underwriting Agreement (Windtree Therapeutics Inc /De/), Underwriting Agreement (Windtree Therapeutics Inc /De/), Underwriting Agreement (Oragenics Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 45 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 18 contracts
Samples: Securities Purchase Agreement (Siyata Mobile Inc.), Securities Purchase Agreement (Siyata Mobile Inc.), Securities Purchase Agreement (Siyata Mobile Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 15 contracts
Samples: Securities Purchase Agreement (Sunshine Biopharma, Inc), Securities Purchase Agreement (Sunshine Biopharma, Inc), Securities Purchase Agreement (Sunshine Biopharma, Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 30 days after the Closing Date, Date neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for Exempt Issuances.
Appears in 14 contracts
Samples: Securities Purchase Agreement (American International Holdings Corp.), Securities Purchase Agreement (American International Holdings Corp.), Securities Purchase Agreement (OncBioMune Pharmaceuticals, Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 180 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 13 contracts
Samples: Underwriting Agreement (Aprea Therapeutics, Inc.), Securities Purchase Agreement (Integrated Ventures, Inc.), Securities Purchase Agreement (Crown Electrokinetics Corp.)
Subsequent Equity Sales. (a) From the date hereof until 90 sixty (60) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 12 contracts
Samples: Underwriting Agreement (Cleanspark, Inc.), Underwriting Agreement (It Tech Packaging, Inc.), Securities Purchase Agreement (Genius Brands International, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 75 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 11 contracts
Samples: Securities Purchase Agreement (Atossa Genetics Inc), Securities Purchase Agreement (Digital Ally Inc), Securities Purchase Agreement (Trovagene, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 10 contracts
Samples: Securities Purchase Agreement (GeoVax Labs, Inc.), Securities Purchase Agreement (GeoVax Labs, Inc.), Securities Purchase Agreement (Genprex, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, this Section 4.18 shall not apply in respect of an Exempt Issuance.
Appears in 8 contracts
Samples: Underwriting Agreement (AquaBounty Technologies, Inc.), Underwriting Agreement (AquaBounty Technologies, Inc.), Underwriting Agreement (AquaBounty Technologies, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents.
Appears in 8 contracts
Samples: Securities Purchase Agreement (Siyata Mobile Inc.), Securities Purchase Agreement (Antelope Enterprise Holdings LTD), Securities Purchase Agreement (Antelope Enterprise Holdings LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 one hundred eighty (180) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, without the prior written approval of the Representative.
Appears in 8 contracts
Samples: Underwriting Agreement (Lafayette Energy Corp.), Underwriting Agreement (Lafayette Energy Corp.), Underwriting Agreement (Lafayette Energy Corp.)
Subsequent Equity Sales. (a) From the date hereof until 90 30 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 8 contracts
Samples: Securities Purchase Agreement (AgEagle Aerial Systems Inc.), Securities Purchase Agreement (Trovagene, Inc.), Securities Purchase Agreement (AgEagle Aerial Systems Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 forty-five (45) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 7 contracts
Samples: Underwriting Agreement (Intelligent Bio Solutions Inc.), Securities Purchase Agreement (Oncternal Therapeutics, Inc.), Securities Purchase Agreement (Ekso Bionics Holdings, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 7 contracts
Samples: Securities Purchase Agreement (Simtek Corp), Securities Purchase Agreement (Gigabeam Corp), Securities Purchase Agreement (Cytogen Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing DateDate except for Exempt Issuances, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Adhera Therapeutics, Inc.), Securities Purchase Agreement (Adhera Therapeutics, Inc.), Securities Purchase Agreement (Adhera Therapeutics, Inc.)
Subsequent Equity Sales. (ai) From the date hereof until 90 days six months after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 6 contracts
Samples: Underwriting Agreement (Guardion Health Sciences, Inc.), Underwriting Agreement (Guardion Health Sciences, Inc.), Underwriting Agreement (Guardion Health Sciences, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 calendar days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 6 contracts
Samples: Securities Purchase Agreement, Securities Purchase Agreement (Real Goods Solar, Inc.), Securities Purchase Agreement (Uni-Pixel)
Subsequent Equity Sales. (a) From the date hereof until 90 days twenty (20) Trading Days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Top Ships Inc.), Securities Purchase Agreement (Top Ships Inc.), Securities Purchase Agreement (Top Ships Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 15 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Sunhydrogen, Inc.), Securities Purchase Agreement (Xenetic Biosciences, Inc.), Securities Purchase Agreement (Bio-Path Holdings Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the sixty (60) day anniversary of the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 5 contracts
Samples: Underwriting Agreement (Applied UV, Inc.), Underwriting Agreement (Applied UV, Inc.), Underwriting Agreement (Applied UV, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 120 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Ohr Pharmaceutical Inc), Securities Purchase Agreement (Ohr Pharmaceutical Inc), Securities Purchase Agreement (Biostage, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 30 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Oragenics Inc), Securities Purchase Agreement (Genprex, Inc.), Securities Purchase Agreement (Genprex, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one-hundred (100) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents, other than the Securities, or file any registration statement.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Seanergy Maritime Holdings Corp.), Securities Purchase Agreement (Seanergy Maritime Holdings Corp.), Securities Purchase Agreement (Seanergy Maritime Holdings Corp.)
Subsequent Equity Sales. (a) From the date hereof until 90 sixty (60) days after the Final Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Tian Ruixiang Holdings LTD), Securities Purchase Agreement (Tian Ruixiang Holdings LTD), Securities Purchase Agreement (Ebang International Holdings Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 180 days after from the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Underwriting Agreement (U.S. GoldMining Inc.), Underwriting Agreement (U.S. GoldMining Inc.), Underwriting Agreement (U.S. GoldMining Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 the date that is 60 calendar days after from the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents at a price less than the Per Share Purchase Price.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Cleanspark, Inc.), Securities Purchase Agreement (Arcimoto Inc), Securities Purchase Agreement (Arcimoto Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 180 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Parallax Health Sciences, Inc.), Securities Purchase Agreement (Rennova Health, Inc.), Securities Purchase Agreement (RLJ Entertainment, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 30 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Dragonwave Inc), Securities Purchase Agreement (COPsync, Inc.), Securities Purchase Agreement (COPsync, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) calendar days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Form of Securities Purchase Agreement (Inuvo, Inc.), Form of Securities Purchase Agreement (Inuvo, Inc.), Form of Securities Purchase Agreement (Inuvo, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one hundred eighty (180) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, without the prior written approval of the Representative and subject to Section 4.20.
Appears in 4 contracts
Samples: Underwriting Agreement (Worksport LTD), Underwriting Agreement (Worksport LTD), Underwriting Agreement (Worksport LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 ten (10) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement.
Appears in 4 contracts
Samples: Share Purchase Agreement (Sintx Technologies, Inc.), Share Purchase Agreement (Sintx Technologies, Inc.), Share Purchase Agreement (Sintx Technologies, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Ebang International Holdings Inc.), Securities Purchase Agreement (Ebang International Holdings Inc.), Securities Purchase Agreement (Ebang International Holdings Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 seventy-five (75) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Underwriting Agreement (Toughbuilt Industries, Inc), Underwriting Agreement (Toughbuilt Industries, Inc), Underwriting Agreement (Artelo Biosciences, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days eighteen (18) Trading Days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Top Ships Inc.), Securities Purchase Agreement (Top Ships Inc.), Securities Purchase Agreement (Top Ships Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Underwriting Agreement (Windtree Therapeutics Inc /De/), Underwriting Agreement (AMEDICA Corp), Underwriting Agreement (AMEDICA Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Datehereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 4 contracts
Samples: Underwriting Agreement (Atossa Therapeutics, Inc.), Underwriting Agreement (Atossa Therapeutics, Inc.), Underwriting Agreement (Bio Key International Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (Can-Fite BioPharma Ltd.)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Shares Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Rosetta Genomics Ltd.), Securities Purchase Agreement (Rosetta Genomics Ltd.), Securities Purchase Agreement (Rosetta Genomics Ltd.)
Subsequent Equity Sales. (a) From the date hereof until 90 105 days after following the Closing Date, neither the Company nor any Subsidiary shall issue, issue or enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Oxygen Biotherapeutics, Inc.), Securities Purchase Agreement (Oxygen Biotherapeutics, Inc.), Securities Purchase Agreement (Oxygen Biotherapeutics, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any binding agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Quanergy Systems, Inc.), Underwriting Agreement (Quanergy Systems, Inc.), Quanergy Systems, Inc.
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. In addition, for a period of twelve (12) months following the Closing Date, the Company shall not draw down on any “at the market”, equity line facility or similar facility.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Rexahn Pharmaceuticals, Inc.), Securities Purchase Agreement (Rexahn Pharmaceuticals, Inc.), Securities Purchase Agreement (Rexahn Pharmaceuticals, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one hundred and eighty (180) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Sun BioPharma, Inc.), Underwriting Agreement (Sun BioPharma, Inc.), Underwriting Agreement (Sun BioPharma, Inc.)
Subsequent Equity Sales. (ab) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Celsion CORP), Securities Purchase Agreement (Celsion CORP), Securities Purchase Agreement (Cemtrex Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 forty-five (45) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, other than the filing of a registration statement on Form S-1.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Diffusion Pharmaceuticals Inc.), Form of Securities Purchase Agreement (Diffusion Pharmaceuticals Inc.), Securities Purchase Agreement (Diffusion Pharmaceuticals Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADRs, ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Edap TMS Sa), Securities Purchase Agreement (Edap TMS Sa), Securities Purchase Agreement (Edap TMS Sa)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (ATIF Holdings LTD), Securities Purchase Agreement (MingZhu Logistics Holdings LTD), Securities Purchase Agreement (Rosetta Genomics Ltd.)
Subsequent Equity Sales. (a) From the date hereof until 90 seventy-five (75) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Powerbridge Technologies Co., Ltd.), Underwriting Agreement (Powerbridge Technologies Co., Ltd.), Underwriting Agreement (Powerbridge Technologies Co., Ltd.)
Subsequent Equity Sales. (a) From the date hereof until the 90 days after day anniversary of the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Jaguar Health, Inc.), Underwriting Agreement (Diffusion Pharmaceuticals Inc.), Diffusion Pharmaceuticals Inc.
Subsequent Equity Sales. (a) From the date hereof until 90 six (6) months days after the Closing Date, neither the Company nor any Subsidiary subsidiary of the Company shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (Innovation Beverage Group LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 45 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Soliton, Inc.), Securities Purchase Agreement (Leafbuyer Technologies, Inc.), Securities Purchase Agreement (AMERI Holdings, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one-hundred eighty (180) days after the Closing Date, neither the Company nor any Subsidiary subsidiary of the Company shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Innovative Eyewear Inc), Underwriting Agreement (Innovative Eyewear Inc), Underwriting Agreement (Innovative Eyewear Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the thirty (30) day anniversary of the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Palatin Technologies Inc), Underwriting Agreement (Pulmatrix, Inc.), Underwriting Agreement (Pulmatrix, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Trovagene, Inc.), Form of Securities Purchase Agreement (Oxigene Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 75 days after the Closing Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Cellectar Biosciences, Inc.), Securities Purchase Agreement (Acorn Energy, Inc.), Securities Purchase Agreement (Spherix Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Can-Fite BioPharma Ltd.), Securities Purchase Agreement (CollPlant Biotechnologies LTD), Securities Purchase Agreement (Medigus Ltd.)
Subsequent Equity Sales. (a) From the date hereof until 90 three hundred sixty-five (365) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Smart for Life, Inc.), Underwriting Agreement (Smart for Life, Inc.), Underwriting Agreement (Smart for Life, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 the date that is ninety (90) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Benitec Biopharma Inc.), Underwriting Agreement (Benitec Biopharma Inc.), Underwriting Agreement (Benitec Biopharma Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 __ days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Spherix Inc), Securities Purchase Agreement (Copytele Inc), Securities Purchase Agreement (Apps Genius Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Datedate hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Aethlon Medical Inc), Securities Purchase Agreement (Aethlon Medical Inc), Securities Purchase Agreement (CONTRAFECT Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Bos Better Online Solutions LTD), Securities Purchase Agreement (Check-Cap LTD), Securities Purchase Agreement (Rosetta Genomics Ltd.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (PECK Co HOLDINGS, INC.), Securities Purchase Agreement (ONCOSEC MEDICAL Inc), Securities Purchase Agreement (ONCOSEC MEDICAL Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 15 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Form of Securities Purchase Agreement (ReWalk Robotics Ltd.), Securities Purchase Agreement (ReWalk Robotics Ltd.), Securities Purchase Agreement (Check-Cap LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Aptorum Group LTD), Securities Purchase Agreement (ReWalk Robotics Ltd.), Securities Purchase Agreement (Ability Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Cibus, Inc., Securities Purchase Agreement (Clearone Inc), Underwriting Agreement (Achieve Life Sciences, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Dateninety (90) day anniversary of the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Lakeland Industries Inc), Apricus Biosciences, Inc., Apricus Biosciences, Inc.
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior consent of the Required Purchasers.
Appears in 3 contracts
Samples: Common Stock Purchase Agreement (Dataram Corp), Securities Purchase Agreement (Dataram Corp), Securities Purchase Agreement (Dataram Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 forty five (45) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Iterum Therapeutics PLC), Securities Purchase Agreement (Iterum Therapeutics PLC), Securities Purchase Agreement (Iterum Therapeutics PLC)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the ninety (90) day anniversary of the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Underwriting Agreement (Ranpak Holdings Corp.), Underwriting Agreement (Bellerophon Therapeutics, Inc.), Underwriting Agreement (Aytu Bioscience, Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 15 days after the Closing Date, neither the Company nor any Subsidiary shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Repros Therapeutics Inc.), RPRX Securities Purchase Agreement (Repros Therapeutics Inc.), Securities Purchase Agreement (Repros Therapeutics Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or file any registration statement or amendment or supplement thereto, other than the Prospectus.
Appears in 3 contracts
Samples: Underwriting Agreement (Peraso Inc.), Underwriting Agreement (Peraso Inc.), Underwriting Agreement (Peraso Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ___ days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Marina Biotech, Inc.), Securities Purchase Agreement (Marina Biotech, Inc.), Securities Purchase Agreement (Nephros Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 forty-five (45) days after the Closing DateDate (the “Lock-Up Period”), neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Check-Cap LTD), Securities Purchase Agreement (Check-Cap LTD), Securities Purchase Agreement (Check-Cap LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 3 contracts
Samples: Securities Purchase Agreement (Z Trim Holdings, Inc), Securities Purchase Agreement (Z Trim Holdings, Inc), Securities Purchase Agreement (Z Trim Holdings, Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 fifteen (15) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Immuron LTD), Securities Purchase Agreement (Genetic Technologies LTD)
Subsequent Equity Sales. (a) From Except for the Series A Preferred Stock Offering, from the date hereof until 90 one hundred and eighty (180) days after from the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Underwriting Agreement (Healthy Choice Wellness Corp.), Underwriting Agreement (Healthy Choice Wellness Corp.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall not (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Cheetah Net Supply Chain Service Inc.), Securities Purchase Agreement (Cheetah Net Supply Chain Service Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days six months after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Underwriting Agreement (Summit Wireless Technologies, Inc.), Underwriting Agreement (Nanoviricides, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 the later of (i) ninety (90) days after the Closing DateDate and (ii) fifteen (15) days following the date Shareholder Approval is received and effective, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Underwriting Agreement (Intelligent Bio Solutions Inc.), Underwriting Agreement (Intelligent Bio Solutions Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 thirty (30) days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.. As used herein “
Appears in 2 contracts
Samples: Warrant Exercise Agreement (Akers Biosciences, Inc.), Warrant Exercise Agreement (PARETEUM Corp)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (IMAC Holdings, Inc.), Securities Purchase Agreement (Super League Gaming, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 180 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except in connection with the transactions otherwise permitted under the Transaction Documents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Sg Blocks, Inc.), Securities Purchase Agreement (Sg Blocks, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 120 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (ONCOSEC MEDICAL Inc), Securities Purchase Agreement (ONCOSEC MEDICAL Inc)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Mad Catz Interactive Inc), Securities Purchase Agreement (Uranium Resources Inc /De/)
Subsequent Equity Sales. (a) From the date hereof until 90 60 days after the Closing Datedate hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Castellum, Inc.), Securities Purchase Agreement (Cingulate Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 150 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (NXT-Id, Inc.), Securities Purchase Agreement (DelMar Pharmaceuticals, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for Securities issued pursuant hereto, without the prior written consent of the Representive, on behalf of the underwriters.
Appears in 2 contracts
Samples: Letter Agreement (Ekso Bionics Holdings, Inc.), Underwriting Agreement (Ekso Bionics Holdings, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 120 days after the Closing Effective Date, other than with respect of an Exempt Issuance, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Ecoark Holdings, Inc.), Securities Purchase Agreement (Ecoark Holdings, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one hundred eight (180) days after the Closing Date, without the prior written consent of the Representative, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Underwriting Agreement (Actuate Therapeutics, Inc.), Underwriting Agreement (Actuate Therapeutics, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Final Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (U Power LTD), Securities Purchase Agreement (SHENGFENG DEVELOPMENT LTD)
Subsequent Equity Sales. (a) From the date hereof until 90 the date that is ninety (90) days after following the Closing Stockholder Approval Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Underwriting Agreement (Benitec Biopharma Inc.), Underwriting Agreement (Benitec Biopharma Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 ninety (90) days after the Closing Date, neither the Company nor any Subsidiary shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or file any registration statement or amendment or supplement thereto, other than the Prospectus.
Appears in 2 contracts
Samples: Underwriting Agreement (NovaBay Pharmaceuticals, Inc.), Underwriting Agreement (NovaBay Pharmaceuticals, Inc.)
Subsequent Equity Sales. (a) From the date hereof until 90 one hundred and eighty (180) days after the Closing Date, without Purchaser’s consent, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common common Stock or Common Stock Equivalents.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Opgen Inc), Securities Purchase Agreement (Minim, Inc.)
